Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series.

Autor: Shimbu, Kaoruko (AUTHOR), Hisakane, Kakeru (AUTHOR), Kadoma, Naohiro (AUTHOR), Nishima, Shunichi (AUTHOR), Atsumi, Kenichiro (AUTHOR), Seike, Masahiro (AUTHOR), Hirose, Takashi (AUTHOR)
Zdroj: OncoTargets & Therapy. Aug2024, Vol. 17, p717-726. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje